Shareholders' equity · 2011–2025
Puma Biotechnology shareholders' equity
$130M+41.5% · FY2025
Puma Biotechnology (PBYI) reported $130M in shareholders' equity for fiscal 2025, +41.5% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $130M | +41.5% | Open → |
| FY20242024-12-31 | $92.1M | +72.4% | Open → |
| FY20232023-12-31 | $53.4M | +147.3% | Open → |
| FY20222022-12-31 | $21.6M | +$24.1M | Open → |
| FY20212021-12-31 | −$2.4M | +$3.5M | Open → |
| FY20202020-12-31 | −$6.0M | −$23.4M | Open → |
| FY20192019-12-31 | $17.5M | −49.1% | Open → |
| FY20182018-12-31 | $34.3M | −35.6% | Open → |
| FY20172017-12-31 | $53.3M | −74.6% | Open → |
| FY20162016-12-31 | $210M | +1.9% | Open → |
| FY20152015-12-31 | $206M | +76.0% | Open → |
| FY20142014-12-31 | $117M | +39.4% | Open → |
| FY20132013-12-31 | $84.0M | −34.8% | Open → |
| FY20122012-12-31 | $129M | +137.1% | Open → |
| FY20112011-12-31 | $54.4M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +6.4%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Puma Biotechnology shareholders' equity |url=https://companiesranked.com/en/company/puma-biotechnology/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Puma Biotechnology shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/puma-biotechnology/shareholders-equityBibTeX
@misc{companiesranked-en-company-puma-biotechnology-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Puma Biotechnology shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/puma-biotechnology/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001437749-26-026311 · August 6, 2026
{{cite web |title=Puma Biotechnology shareholders' equity — 10-Q (0001437749-26-026311) |url=https://www.sec.gov/Archives/edgar/data/1401667/000143774926026311/pbyi20260630_10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.